Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1147 ARTÍCULOS , VIENDO DEL 601 AL 615

Modelling the clinical and economic implications of galantamine in the treatment of mild-to-moderate Alzheimer's disease in Germany

Guo S, Hernandez L, Wasiak R, Gaudig M.

J Med Econ. 2010;13(4):641-54. doi: 10.3111/13696998.2010.528101. Epub 2010 Oct 19.

[An autopsy case of senile dementia suspected to be influenced by cerebral amyloid angiopathy with multiple cortical microinfarcts]

Iwasaki Y, Mori K, Ito M, Deguchi A, Shiraishi T, Mimuro M, Yoshida M, Hashizume Y.

Rinsho Shinkeigaku. 2010 Sep;50(9):651-5. doi: 10.5692/clinicalneurol.50.651.

When neurogenesis encounters aging and disease

Lazarov O, Mattson MP, Peterson DA, Pimplikar SW, van Praag H.

Trends Neurosci. 2010 Dec;33(12):569-79. doi: 10.1016/j.tins.2010.09.003. Epub 2010 Oct 18.

Apolipoprotein E polymorphism in cerebrovascular & coronary heart diseases

Anoop S, Misra A, Meena K, Luthra K.

Indian J Med Res. 2010 Oct;132:363-78.

Linking Alzheimer's disease to insulin resistance: the FoxO response to oxidative stress

Manolopoulos KN, Klotz LO, Korsten P, Bornstein SR, Barthel A.

Mol Psychiatry. 2010 Nov;15(11):1046-52. doi: 10.1038/mp.2010.17.

[Alteration of calcium signaling as one of the mechanisms of Alzheimer's disease and diabetic polyneuropathy]

Kostiuk OP, Korol' TIu, Korol' SV, Romanenko SV, Pinchenko VO, Kostiuk PH.

Fiziol Zh (1994). 2010;56(4):130-8.

Is dementia preventable? Focus on Alzheimer's disease

Barak Y, Aizenberg D.

Expert Rev Neurother. 2010 Nov;10(11):1689-98. doi: 10.1586/ern.10.159.

Video-based coping skills to reduce health risk and improve psychological and physical well-being in Alzheimer's disease family caregivers

Williams VP, Bishop-Fitzpatrick L, Lane JD, Gwyther LP, Ballard EL, Vendittelli AP, Hutchins TC, Williams RB.

Psychosom Med. 2010 Nov;72(9):897-904. doi: 10.1097/PSY.0b013e3181fc2d09. Epub 2010 Oct 26.

[Memantine in the pharmacologic treatment of moderately severe to severe Alzheimer's disease in Spain (MEMORY study)]

Agüera-Ortiz LF; Grupo de Investigadores del Estudio MEMORY.

Rev Neurol. 2010 Nov 1;51(9):525-34.

APOE varepsilon2 and presymptomatic stage Alzheimer disease: how much is not enough?

Caselli RJ, Dueck AC.

Neurology. 2010 Nov 30;75(22):1952-3. doi: 10.1212/WNL.0b013e3181ff94f7. Epub 2010 Oct 27.

Anti-tau oligomers passive vaccination for the treatment of Alzheimer disease

Kayed R.

Hum Vaccin. 2010 Nov;6(11):931-5. doi: 10.4161/hv.6.11.12689. Epub 2010 Nov 1.

Simplified β-amyloid peptides for safer Alzheimer's vaccines development

Verdoliva A, Rivieccio V, Rossi M.

Hum Vaccin. 2010 Nov;6(11):936-47. doi: 10.4161/hv.6.11.13034. Epub 2010 Nov 1.

Phosphorylation of APP-CTF-AICD domains and interaction with adaptor proteins: signal transduction and/or transcriptional role--relevance for Alzheimer pathology

Schettini G, Govoni S, Racchi M, Rodriguez G.

J Neurochem. 2010 Dec;115(6):1299-308. doi: 10.1111/j.1471-4159.2010.07044.x. Epub 2010 Nov 4.

Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial

Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR Jr, Weiner M, Shinto L, Aisen PS.

JAMA. 2010 Nov 3;304(17):1903-11. doi: 10.1001/jama.2010.1510.

Inflammation and Alzheimer's disease

Lee YJ, Han SB, Nam SY, Oh KW, Hong JT.

Arch Pharm Res. 2010 Oct;33(10):1539-56. doi: 10.1007/s12272-010-1006-7. Epub 2010 Oct 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias